← Back to Briefing
CMS Unveils Participants for New Medicaid Drug Payment Model
Importance: 5/1001 Sources
Why It Matters
This new payment model could significantly alter drug pricing and reimbursement within Medicaid, potentially leading to substantial cost savings for states and improved access to affordable medications for millions of beneficiaries.
Key Intelligence
- ■The Centers for Medicare & Medicaid Services (CMS) has announced the participants for its new Medicaid drug payment model.
- ■This initiative aims to implement a landmark approach to bring down prescription drug costs within the Medicaid program.
- ■The model is designed to innovate how drugs are paid for, potentially leading to more affordable medications for beneficiaries.